As Costa Ricans cast their ballots this Sunday, the election is defined by unprecedented security fears, economic inequality, and widespread political disenchantment, challenging the country's long-held identity as a peaceful and stable democracy.
As the ASX braces for a turbulent week amid rate hike fears, investors are scouring the market for resilient opportunities. We delve into three penny stocks—spanning energy, retail, and healthcare—that combine financial stability with distinct growth narratives for the discerning investor.
Doctors Without Borders (MSF) has definitively rejected an Israeli order to hand over sensitive staff information, following months of failed negotiations. The move comes amid a wider crackdown on aid groups and a devastating toll on healthcare workers in the conflict.
After a three-year suspension due to insurgent violence, TotalEnergies and Mozambique have agreed to restart one of Africa's largest natural gas developments, raising hopes for economic transformation amid lingering risks.
Lawmakers are negotiating a short-term deal to fund the Department of Homeland Security, aiming to avoid a partial government shutdown this weekend. The talks occur against the backdrop of heightened political pressure following recent violence in Minneapolis and a shift in the administration's enforcement rhetoric.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
Fresh financial data from QuidelOrtho reveals ongoing challenges, including constant currency revenue declines and pressured cash flow, forcing investors to weigh the stock's risk-reward profile as its momentum appears to fade.
While Wall Street chases the latest weight-loss drug headlines, Novo Nordisk's recent launch of an oral GLP-1 therapy and its entrenched insulin business present a compelling value proposition for long-term investors.
French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.
Investment firm Monument Capital Management has completely exited its position in Grand Canyon Education, selling 19,133 shares. The move comes as the education services provider navigates legal challenges and market underperformance.
NVIDIA has significantly revised its once-floated $100 billion investment plan for OpenAI, opting for a more measured commitment. The strategic shift underscores the chipmaker's focus on business discipline and diversifying its partnerships across the booming AI ecosystem, even as it remains central to OpenAI's operations.
A 65-year-old Albany woman, remembered by family as 'the heart of the family,' was fatally shot in her home by a man she had housed for ten years, who then turned the gun on himself.
Philadelphia District Attorney Larry Krasner faces mounting pressure and bipartisan condemnation after publicly threatening to 'hunt down' ICE agents, comparing them to Nazis. A Republican congressman has formally urged the Justice Department to open a criminal investigation into the remarks.
While Medicare provides a crucial safety net at 65, significant gaps in coverage for dental, vision, and long-term care can lead to six-figure annual expenses. Proactive planning with HSAs, specialized insurance, and strategic budgeting is essential to protect retirement savings.
While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
The FDA has issued a complete response letter for Aquestive Therapeutics' sublingual epinephrine film Anaphylm, citing concerns over packaging and user instructions. The company aims to address the issues and resubmit its application by the third quarter of this year.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Syrian government security forces entered the key northeastern city of Hasakeh on Monday, implementing a landmark integration deal with Kurdish authorities. The move marks a significant step in Damascus's campaign to reassert control over the entire country, reshaping the political landscape of northern Syria.
Senior Iranian officials have privately warned Supreme Leader Khamenei that public fury over a recent bloody crackdown has eroded the 'wall of fear,' raising concerns that even a limited U.S. strike could embolden protesters and threaten the regime's stability, according to multiple sources familiar with high-level discussions.
